Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Davita Healthcare Partners Inc (DVA)

Davita Healthcare Partners Inc (DVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,149,439
  • Shares Outstanding, K 91,300
  • Annual Sales, $ 11,619 M
  • Annual Income, $ 978,450 K
  • 60-Month Beta 1.09
  • Price/Sales 0.70
  • Price/Cash Flow 5.41
  • Price/Book 10.53
Trade DVA with:

Options Overview Details

View History
  • Implied Volatility 40.95% ( +1.19%)
  • Historical Volatility 32.91%
  • IV Percentile 85%
  • IV Rank 53.25%
  • IV High 54.49% on 06/16/22
  • IV Low 25.53% on 12/23/21
  • Put/Call Vol Ratio 2.10
  • Today's Volume 31
  • Volume Avg (30-Day) 277
  • Put/Call OI Ratio 1.05
  • Today's Open Interest 26,130
  • Open Int (30-Day) 25,142

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 1.67
  • Number of Estimates 4
  • High Estimate 1.72
  • Low Estimate 1.60
  • Prior Year 2.36
  • Growth Rate Est. (year over year) -29.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.56 +7.70%
on 09/29/22
96.37 -7.73%
on 09/12/22
+0.66 (+0.75%)
since 09/06/22
3-Month
80.63 +10.28%
on 07/07/22
96.37 -7.73%
on 09/12/22
+8.68 (+10.82%)
since 07/06/22
52-Week
74.97 +18.61%
on 06/21/22
124.81 -28.76%
on 04/20/22
-25.21 (-22.09%)
since 10/06/21

Most Recent Stories

More News
DaVita Announces Adam H. Schechter to Join its Board of Directors

/PRNewswire/ -- DaVita Inc. announced today that its Board of Directors appointed a new independent director, Adam H. Schechter, to join the Board, effective...

DVA : 88.92 (-0.38%)
Federman & Sherwood Investigates DaVita, Inc. for Data Breach

The law firm of Federman & Sherwood has initiated an investigation into DaVita, Inc. [NYSE: DVA] with respect to a data breach. On September 8, 2022, DaVita, Inc., a healthcare company with approximately...

DVA : 88.92 (-0.38%)
The 10 Cheapest Warren Buffett Stocks

These Berkshire Hathaway holdings sport forward-year price-to-earnings (P/E) ratios of 4.8 to 9.2.

BRK.A : 416,300.00 (-1.04%)
BRK.B : 276.31 (-1.09%)
ORCL : 65.30 (-2.01%)
BRK-A : N/A (unch)
BRK-B : N/A (unch)
ALLY : 30.30 (-1.27%)
GM : 34.63 (-0.60%)
HPQ : 26.48 (-1.12%)
CE : 92.58 (-2.30%)
C : 43.06 (-1.78%)
OXY : 70.50 (+4.07%)
BAC : 31.46 (-1.44%)
DaVita HealthCare (DVA) Up 0.7% Since Last Earnings Report: Can It Continue?

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

DVA : 88.92 (-0.38%)
Is It Too Late to Get in on This Warren Buffett Stock?

Renowned kidney dialysis provider DaVita (DVA) reported solid second-quarter results. The company is expected to witness massive growth in the coming quarters, backed by strength in DaVita Kidney Care...

ABC : 139.91 (-1.78%)
CAH : 69.44 (+0.07%)
DVA : 88.92 (-0.38%)
MCK : 350.89 (-0.98%)
Stocks Slide on the Outlook for Aggressive Fed Rate Hikes to Continue

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Friday closed down -1.29%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 3,744.52 (-1.02%)
SPY : 373.20 (-1.03%)
$DOWI : 29,926.94 (-1.15%)
DIA : 299.23 (-1.18%)
$IUXX : 11,485.50 (-0.76%)
QQQ : 279.76 (-0.79%)
OKTA : 58.01 (-2.49%)
ZS : 182.92 (+1.54%)
LRCX : 397.60 (-0.58%)
NVDA : 131.30 (-0.60%)
AMD : 67.85 (-0.13%)
TEAM : 238.99 (-1.43%)
Stocks Fall as Fed Comments Signal Aggressive Rate Hikes to Continue

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -1.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.62%....

$SPX : 3,744.52 (-1.02%)
SPY : 373.20 (-1.03%)
$DOWI : 29,926.94 (-1.15%)
DIA : 299.23 (-1.18%)
$IUXX : 11,485.50 (-0.76%)
QQQ : 279.76 (-0.79%)
OKTA : 58.01 (-2.49%)
DDOG : 93.66 (-1.52%)
TEAM : 238.99 (-1.43%)
ZS : 182.92 (+1.54%)
LRCX : 397.60 (-0.58%)
NVDA : 131.30 (-0.60%)
Down 26%, Is This Buffett Stock a Buy?

Warren Buffett loves to own cash-generating "toll bridge" companies. DaVita qualifies on both counts.

BRK.A : 416,300.00 (-1.04%)
BRK.B : 276.31 (-1.09%)
DVA : 88.92 (-0.38%)
DaVita (DVA) Beats on Q2 Earnings, Reiterates FY22 EPS View

DaVita (DVA) records an overall solid Q2 performance owing to strength in its Other segment's revenues and uptick in total U.S. dialysis treatments.

ALKS : 22.81 (-1.38%)
DGX : 126.06 (-1.33%)
DVA : 88.92 (-0.38%)
HUM : 499.30 (-1.07%)
DaVita (DVA) Q2 2022 Earnings Call Transcript

DVA earnings call for the period ending June 30, 2022.

DVA : 88.92 (-0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals...

See More

Key Turning Points

3rd Resistance Point 90.76
2nd Resistance Point 90.21
1st Resistance Point 89.57
Last Price 88.92
1st Support Level 88.38
2nd Support Level 87.83
3rd Support Level 87.19

See More

52-Week High 124.81
Fibonacci 61.8% 105.77
Fibonacci 50% 99.89
Fibonacci 38.2% 94.01
Last Price 88.92
52-Week Low 74.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar